- Home
- ASGN vs KNSA Comparison
ASGN vs KNSA Comparison
Compare ASGN & KNSA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ASGN
- KNSA
- Stock Information
- Founded
- ASGN 1985
- KNSA 2015
- Country
- ASGN United States
- KNSA United Kingdom
- Employees
- ASGN N/A
- KNSA N/A
- Industry
- ASGN Professional Services
- KNSA Biotechnology: Pharmaceutical Preparations
- Sector
- ASGN Consumer Discretionary
- KNSA Health Care
- Exchange
- ASGN Nasdaq
- KNSA Nasdaq
- Market Cap
- ASGN 2.3B
- KNSA 1.9B
- IPO Year
- ASGN 1992
- KNSA 2018
- Fundamental
- Price
- ASGN $53.06
- KNSA $35.71
- Analyst Decision
- ASGN Hold
- KNSA Strong Buy
- Analyst Count
- ASGN 6
- KNSA 6
- Target Price
- ASGN $61.67
- KNSA $40.83
- AVG Volume (30 Days)
- ASGN 464.9K
- KNSA 439.9K
- Earning Date
- ASGN 10-22-2025
- KNSA 10-28-2025
- Dividend Yield
- ASGN N/A
- KNSA N/A
- EPS Growth
- ASGN N/A
- KNSA N/A
- EPS
- ASGN 3.15
- KNSA 0.07
- Revenue
- ASGN $4,004,900,000.00
- KNSA $529,332,000.00
- Revenue This Year
- ASGN N/A
- KNSA $37.21
- Revenue Next Year
- ASGN $2.42
- KNSA $11.99
- P/E Ratio
- ASGN $16.62
- KNSA $539.78
- Revenue Growth
- ASGN N/A
- KNSA 56.18
- 52 Week Low
- ASGN $46.64
- KNSA $17.82
- 52 Week High
- ASGN $101.66
- KNSA $35.82
- Technical
- Relative Strength Index (RSI)
- ASGN 53.24
- KNSA 72.49
- Support Level
- ASGN $51.94
- KNSA $33.25
- Resistance Level
- ASGN $54.26
- KNSA $34.16
- Average True Range (ATR)
- ASGN 1.61
- KNSA 0.83
- MACD
- ASGN 0.03
- KNSA 0.07
- Stochastic Oscillator
- ASGN 59.07
- KNSA 95.59
About ASGN ASGN Incorporated
ASGN Inc is a provider of information technology (IT) services and professional solutions, including technology, creative, and digital, across the commercial and government sectors. It operates through two segments, Commercial and Federal Government. The Commercial Segment, which generates the majority of the revenue, provides consulting, creative digital marketing, and permanent placement services to Fortune 1000 clients and mid-market companies. The Federal Government Segment provides mission-critical solutions to the Department of Defense, intelligence agencies, and civilian agencies.
About KNSA Kiniksa Pharmaceuticals Ltd.
Kiniksa Pharmaceuticals International PLC is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases. The company's clinical-stage product candidates include Rilonacept, abiprubart, and mavrilimumab.